4.8 Article

Variability of multi-omics profiles in a population-based child cohort

期刊

BMC MEDICINE
卷 19, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12916-021-02027-z

关键词

Multi-omics; Exposome; Variability; Population study; Metabolomics; DNA methylation; Cross-omics; mRNA; miRNA; Children

资金

  1. European Community's Seventh Framework Programme (FP7/2007-206) [308333, H2020-EU.3.1.2, 874583]
  2. Wellcome Trust [WT101597MA]
  3. UK Medical Research Council (MRC) [MR/N024397/1]
  4. Economic and Social Science Research Council (ESRC) [MR/N024397/1]
  5. Instituto de Salud Carlos III, CIBERESP
  6. Lithuanian Agency for Science Innovation and Technology [6-04-2014_31V-66]
  7. European projects (EU) [211250]
  8. Greek Ministry of Health
  9. Instituto de Salud Carlos III (ISCIII) [PT17/0019]
  10. ERDF
  11. Spanish Ministry of Science and Innovation and State Research Agency through the Centro de Excelencia Severo Ochoa [CEX2018-000806-S]
  12. Generalitat de Catalunya through the CERCA Program [CEX2018-000806-S]
  13. FI fellowship from the Catalan Government (FI-DGR) [016FI_B 00272]
  14. Instituto Carlos III (Ministry of Economy and Competitiveness) [MS16/00128]
  15. Juan de la Cierva-Incorporacion fellowship - Spanish Ministerio de Economia, Industria y Competitividad [IJC2018-035394-I]
  16. Generalitat de Catalunya-CIRIT

向作者/读者索取更多资源

The study assessed the intra- and inter-individual variability of multiple omics profiles in healthy children from Europe, finding DNA methylation to be the most stable and gene expression to be the least stable feature. Explanatory variables such as age and BMI explained up to 9% of serum metabolite variability, highlighting the importance of controlling for sample collection and individual traits in omics studies.
Background Multiple omics technologies are increasingly applied to detect early, subtle molecular responses to environmental stressors for future disease risk prevention. However, there is an urgent need for further evaluation of stability and variability of omics profiles in healthy individuals, especially during childhood. Methods We aimed to estimate intra-, inter-individual and cohort variability of multi-omics profiles (blood DNA methylation, gene expression, miRNA, proteins and serum and urine metabolites) measured 6 months apart in 156 healthy children from five European countries. We further performed a multi-omics network analysis to establish clusters of co-varying omics features and assessed the contribution of key variables (including biological traits and sample collection parameters) to omics variability. Results All omics displayed a large range of intra- and inter-individual variability depending on each omics feature, although all presented a highest median intra-individual variability. DNA methylation was the most stable profile (median 37.6% inter-individual variability) while gene expression was the least stable (6.6%). Among the least stable features, we identified 1% cross-omics co-variation between CpGs and metabolites (e.g. glucose and CpGs related to obesity and type 2 diabetes). Explanatory variables, including age and body mass index (BMI), explained up to 9% of serum metabolite variability. Conclusions Methylation and targeted serum metabolomics are the most reliable omics to implement in single time-point measurements in large cross-sectional studies. In the case of metabolomics, sample collection and individual traits (e.g. BMI) are important parameters to control for improved comparability, at the study design or analysis stage. This study will be valuable for the design and interpretation of epidemiological studies that aim to link omics signatures to disease, environmental exposures, or both.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据